Effects of Dexmedetomidine on the Liver Injury After Hepatectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 2, 2016

Primary Completion Date

January 26, 2017

Study Completion Date

January 26, 2017

Conditions
Ischemia-reperfusion Injury
Interventions
DRUG

dexmedetomidine

dexmedetomidine 2mg is diluted in 0.9% sodium chloride with the concentration of 4 ug ml-1 is administered with an loading dose of 0.5ug kg-1 of 10 min, and maintained with infusion rate of 0.5 ug kg-1 h-1. The infusion is ceased after the resection of the hepatic issues.

DRUG

0.9% sodium chloride

0.9% sodium chloride is administered with an loading dose of 0.5ug kg-1 of 10 min, and maintained with infusion rate of 0.5 ug kg-1 h-1. The infusion is ceased after the resection of the hepatic issues.

Trial Locations (1)

100853

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT02833688 - Effects of Dexmedetomidine on the Liver Injury After Hepatectomy | Biotech Hunter | Biotech Hunter